„Minimal Clinically Important Difference“ (MCID) der Impulsoszillometrie bei Patienten mit Asthma bronchiale
Mustafa Abdo(Heidelberg University), Thomas Bahmer(Christian-Albrechts-Universität zu Kiel), Anne‐Marie Kirsten, Erika von Mutius(German Center for Lung Research), Gesine Hansen(Medizinische Hochschule Hannover), Frederik Trinkmann(Heidelberg University), H Watz(LungenClinic Grosshansdorf), MV Kopp(University Hospital of Bern), Klaus F. Rabe(Christian-Albrechts-Universität zu Kiel)
Cited by 0
Related Papers
Exposure to Environmental Microorganisms and Childhood Asthma
|New England Journal of Medicine|2011|1.5k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452